BMX-001 as a Therapeutic Agent for Treatment of Cancer Patients with Multiple Brain Metastases

Grants and Contracts Details

StatusFinished
Effective start/end date1/23/20 → 5/31/24

Funding

  • BioMimetix JV LLC: $242,043.00